我国是食管癌高发区 ,食管癌在我国居恶性肿瘤的第四位[1] 。食管癌的病理分期不仅是判断预后的重要指标 ,也是指导临床治疗的基本依据[2 ] 。近30年中 ,食管癌的病理分期方法在不断地进行着修改 ,如今又有新的发展趋势。了解食管癌TNM分期的现状和发展趋势 ,可以更好地把握今 China is a high incidence of esophageal cancer, esophageal cancer in China ranks fourth in malignant tumors [1]. Pathological staging of esophageal cancer is not only an important indicator of prognosis, but also the basic basis for guiding clinical treatment [2]. Nearly 30 years, the pathological staging of esophageal cancer methods are constantly being modified, and now there are new trends. To understand the status and development trend of esophageal TNM staging, we can better grasp this